 Connection
Mark Lovell to Cognition Disorders
This is a "connection" page, showing publications Mark Lovell has written about Cognition Disorders.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.121 |
|
|
|
-
Lovell MA. Similarities and differences between mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2010; 19(1):219.
Score: 0.254
-
Lynn BC, Wang J, Markesbery WR, Lovell MA. Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer's disease. J Alzheimers Dis. 2010; 19(1):325-39.
Score: 0.254
-
Lovell MA. A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease. J Alzheimers Dis. 2009; 16(3):471-83.
Score: 0.237
-
Shao C, Xiong S, Li GM, Gu L, Mao G, Markesbery WR, Lovell MA. Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain. Free Radic Biol Med. 2008 Sep 15; 45(6):813-9.
Score: 0.228
-
Lovell MA, Markesbery WR. Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res. 2007 Nov 01; 85(14):3036-40.
Score: 0.219
-
Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res. 2007; 35(22):7497-504.
Score: 0.218
-
Lovell MA, Markesbery WR. Oxidatively modified RNA in mild cognitive impairment. Neurobiol Dis. 2008 Feb; 29(2):169-75.
Score: 0.216
-
Markesbery WR, Lovell MA. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch Neurol. 2007 Jul; 64(7):954-6.
Score: 0.214
-
Lovell MA, Smith JL, Markesbery WR. Elevated zinc transporter-6 in mild cognitive impairment, Alzheimer disease, and pick disease. J Neuropathol Exp Neurol. 2006 May; 65(5):489-98.
Score: 0.197
-
Smith JL, Xiong S, Markesbery WR, Lovell MA. Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain. Neuroscience. 2006 Jul 07; 140(3):879-88.
Score: 0.196
-
Wang J, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J Neurochem. 2006 Feb; 96(3):825-32.
Score: 0.193
-
Williams TI, Lynn BC, Markesbery WR, Lovell MA. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol Aging. 2006 Aug; 27(8):1094-9.
Score: 0.186
-
Lovell MA, Smith JL, Xiong S, Markesbery WR. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease. Neurotox Res. 2005; 7(4):265-71.
Score: 0.180
-
Maroon JC, Bailes J, Collins M, Lovell M, Mathyssek C. Age of first exposure to football and later-life cognitive impairment in former NFL players. Neurology. 2015 Sep 15; 85(11):1007.
Score: 0.094
-
Lovell MA, Abner E, Kryscio R, Xu L, Fister SX, Lynn BC. Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production. Oxid Med Cell Longev. 2015; 2015:787805.
Score: 0.093
-
Lovell M. The neurophysiology and assessment of sports-related head injuries. Neurol Clin. 2008 Feb; 26(1):45-62; viii.
Score: 0.056
-
Markesbery WR, Kryscio RJ, Lovell MA, Morrow JD. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol. 2005 Nov; 58(5):730-5.
Score: 0.048
-
Reddy CC, Collins M, Lovell M, Kontos AP. Efficacy of amantadine treatment on symptoms and neurocognitive performance among adolescents following sports-related concussion. J Head Trauma Rehabil. 2013 Jul-Aug; 28(4):260-5.
Score: 0.020
-
Randolph C, Lovell M, Laker SR. Neuropsychological testing point/counterpoint. PM R. 2011 Oct; 3(10 Suppl 2):S433-9.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|